Complizen Learn

FDA compliance for medical devices isn't optional - it's the gateway to the largest medical device market. In the US, “FDA compliance” means: classify  the product (Class I/II/III), choose the correct route— 510(k) clearance , De Novo classification , PMA approval , or 510(k)-exempt —run a compliant quality system  (QSR until Feb 2, 2026 ; QMSR  afterward), apply labeling/UDI  rules, register & list  establishments/devices, and meet postmarket  duties (MDR 803, corrections/re

A combination product combines a medical device with a drug, biologic, or both as a single-entity , co-packaged , or cross-labeled  configuration (21 CFR 3.2(e) ). FDA classification depends on the Primary Mode of Action (PMOA) - whichever component provides the most therapeutic benefit determines which FDA center reviews your product and which regulations apply; if unclear, the Office of Combination Products  decides, and an RFD  yields a binding designation within 60 days  

A predicate device is a legally marketed U.S. device with the same intended use and technological characteristics that do not raise different questions of safety and effectiveness compared with your device. Find candidates in FDA’s Product Classification Database (by product code), FDA’s 510(k) database (by device name/manufacturer), and AccessGUDID (public UDI)—which often lists premarket submission numbers you can pivot on. Pick well and you streamline review; pick poorly a

Importing medical devices into the United States requires strict FDA compliance, and the stakes are massive. Medical device importers must ensure premarket compliance (510(k)/PMA), establishment registration and listing, proper CBP filing codes (DEV, LST, PM#), and ongoing MDR obligations. Foreign manufacturers need US agents while initial importers must maintain complaint files in the US. Products that don't meet requirements face detention, refusal, and destruction, often c

FDA requires medical device labeling to include manufacturer information, intended use, adequate directions, warnings, UDI (where applicable), and device-specific requirements. Labeling encompasses all written materials including labels, packaging, instructions for use, and promotional materials. Compliance requires both content accuracy and quality system controls under 21 CFR 820.120. This guide covers all FDA labeling requirements, common violations, and compliance strateg

Whether you need FDA approval, FDA clearance, or no regulatory submission at all depends on your device's risk classification and intended use. FDA approval (PMA) is required for high-risk Class III devices. FDA clearance (510(k)) is needed for most Class II devices and some Class I devices. However, most Class I devices and many Class II devices are exempt from premarket submissions but still require FDA registration and listing. This guide provides a complete decision frame

Medical device companies expanding globally face a critical strategic decision: which regulatory pathway offers the fastest, most...

A medical device Quality Management System (QMS)  proves you can consistently design, make, and support safe, effective devices. It's...

A Predetermined Change Control Plan (PCCP) is FDA documentation that lets you pre-define specific AI/ML software changes—and the methods...

FDA consensus standards are voluntary international standards that FDA recognizes for medical device submissions. Companies can submit a...

Medical device development runs from concept through design controls, verification and validation, clinical investigations when needed,...

FDA requires packaging that protects devices from alteration or damage  through processing, storage, handling, and distribution ( 21 CFR...

Medical device development costs vary by classification: Class I ($200K-$2M), Class II ($2M-$30M), and Class III ($5M-$119M+). Major expenses include clinical trials (40-60% of budget), regulatory activities (10-15%), manufacturing setup (15-25%), and commercialization (10-20%). Timeline spans 1-7 years depending on complexity and pathway. The #1 question every medtech entrepreneur asks: "How much funding do I actually need?" The answer depends on your device classification,

FDA Design Controls under 21 CFR 820.30 are quality system requirements ensuring medical devices are designed to meet user needs and...

UDI  is FDA’s Unique Device Identification  system: most device labels and packages  must carry a UDI  in machine-readable (AIDC)  and...

The FDA’s Center for Devices and Radiological Health (CDRH) regulates medical devices in the United States. Devices reach the market via...

Medical device clinical trials are FDA-regulated clinical investigations  conducted under 21 CFR 812  to collect safety and effectiveness...

FDA is replacing 21 CFR 820 (Quality System Regulation) with the Quality Management System Regulation (QMSR) on February 2, 2026,...

FDA authorizes medical devices via three pathways: 510(k) clearance  for substantial equivalence, De Novo classification  for novel low to moderate risk, and PMA (Pre-market) approval  for most Class III devices. Under MDUFA V , FDA’s goals are 510(k): 95% within 90 FDA days , De Novo: 70% within 150 FDA days , and PMA average total time to decision ≈ 285 days in FY 2025–2027 . Your device's risk classification and predicate availability determine which pathway applies. This

FDA AI medical device regulation received major updates with comprehensive draft guidance for artificial intelligence-enabled devices. On January 7, 2025 , FDA issued draft guidance  for AI-enabled device software functions (DSF)  that applies a Total Product Life Cycle (TPLC)  approach. It recommends  what to include in submissions: model description, data lineage/splits, performance tied to claims, bias analysis/mitigation, human-AI workflow, monitoring, and—if you’ll updat